SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-056458
Filing Date
2021-11-12
Accepted
2021-11-12 07:22:06
Documents
62
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q pmvp-10q_20210930.htm   iXBRL 10-Q 2230808
2 EX-31.1 pmvp-ex311_8.htm EX-31.1 19923
3 EX-31.2 pmvp-ex312_6.htm EX-31.2 20480
4 EX-32.1 pmvp-ex321_7.htm EX-32.1 9630
5 EX-32.2 pmvp-ex322_9.htm EX-32.2 9858
  Complete submission text file 0001564590-21-056458.txt   7250984

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA pmvp-20210930.xsd EX-101.SCH 48643
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pmvp-20210930_cal.xml EX-101.CAL 40550
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pmvp-20210930_def.xml EX-101.DEF 149112
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pmvp-20210930_lab.xml EX-101.LAB 372173
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pmvp-20210930_pre.xml EX-101.PRE 283631
11 EXTRACTED XBRL INSTANCE DOCUMENT pmvp-10q_20210930_htm.xml XML 1218748
Mailing Address 8 CLARKE DRIVE CRANBURY NJ 08512
Business Address 8 CLARKE DRIVE CRANBURY NJ 08512 (609) 642-6664
PMV Pharmaceuticals, Inc. (Filer) CIK: 0001699382 (see all company filings)

IRS No.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39539 | Film No.: 211399556
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences